Skip to main content

Kazia Therapeutics Ltd

KZIA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001075880

No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.

Superinvestors holding KZIA, Q2 2026

See all superinvestors

No superinvestor reported holding KZIA in Q2 2026.